Forte Biosciences's total assets for Q3 2025 were $97.09M, a decrease of -9.92% from the previous quarter. FBRX total liabilities were $12.99M for the fiscal quarter, a 41.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.